MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.tracli.2026.06.004

Медицинская библиотека · Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine · 2026

Transfusion rate and risk factors in hemiarthroplasty of hip: A nationwide cohort study.

Park Ki-Tae, Park Jung-Wee, Lee Dong-Hoon, Park Soon Young, Han Min-Ji, Lee Young-Kyun

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND/

OBJECTIVES

Hemiarthroplasty for hip fracture is frequently associated with substantial perioperative blood loss; however, nationwide data on transfusion epidemiology and related risk factors remain limited. This study aimed: (1) to assess transfusion rates and temporal trends; (2) to evaluate the use of transfusion-sparing agents; and (3) to identify risk factors of transfusion in a national cohort.

METHODS

Using the Korean National Health Insurance Service database, we included who underwent primary hemiarthroplasty between 2002 and 2020. The trends in transfusion and the use of transfusion-sparing agents were assessed using each procedure and drug codes. Risk factors were evaluated by multivariable logistic regression analysis.

RESULTS

Among 220,278 hemiarthroplasties, 82.0% received transfusion with annual decrease from 86.3 to 72.2% since 2013, and mean transfusion volume decreased from 1386 to 1115mL. The use of anti-fibrinolytic agents and iron supplementation increased gradually, whereas hemostatic agent use decreased. Female, old age, intertrochanteric fracture, preoperative anemia, use of closed suction drainage, hemostatic agents, and hematopoietic agents were associated with an increased transfusion risk, whereas anti-fibrinolytic agents (aOR=0.53; 95% CI 0.52-0.55; P<0.001) and iron supplements (aOR=0.73; 95% CI 0.71-0.76; P<0.001) were associated with significantly decreased transfusion risk.

CONCLUSION

In this nationwide cohort, transfusion after hemiarthroplasty remained common, but declined gradually over two decades. The use of anti-fibrinolytic agents and iron supplementation was associated with a decreased risk of transfusion, supporting the implementation of patient blood management (PBM) strategies for hip fracture surgery.

Для цитирования: Park Ki-Tae, Park Jung-Wee, Lee Dong-Hoon, Park Soon Young, Han Min-Ji, Lee Young-Kyun. Transfusion rate and risk factors in hemiarthroplasty of hip: A nationwide cohort study.. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 2026. DOI: 10.1016/j.tracli.2026.06.004.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.